This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael D. Vanheyst: Inventor of a Nav1.8 Inhibitor Patent.
Introduction
Michael D. Vanheyst is an inventor associated with Harleysville, Pennsylvania, and Merck Sharp & Dohme LLC. His patent work includes a pharmaceutical invention focused on compounds that inhibit Nav1.8 channel activity.
Latest Patents
Vanheyst is named on 1 patent: “Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as Nav1.8 inhibitors.” The patent describes novel compounds and their pharmaceutically acceptable salts as inhibitors of Nav1.8 channel activity. These compounds may have potential applications in treating, preventing, managing, ameliorating, controlling, or suppressing conditions mediated by that activity, including pain, cough, acute itch, and chronic itch disorders.
Career Highlights
Vanheyst’s listed patent reflects work in pharmaceutical research and the development of compounds targeting Nav1.8. The patent identifies Merck Sharp & Dohme LLC as his company affiliation.
Collaborations
Ashok Arasappan is identified as Vanheyst’s coworker. Their shared professional context is associated with Merck Sharp & Dohme LLC.
Conclusion
Michael D. Vanheyst’s patent documents a potential therapeutic approach to Nav1.8-related conditions, including pain and itch disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile